Urinary TGF-β1 was not independently associated with renal function in diabetes mellitus

References

• Mcknight AJ Duffy S Maxwell AP Maxwell AP Mcknight AJ Genetics of Diabetic Nephropathy: a Long Road of Discovery Curr Diab Rep 2015 15 7 1 11
   Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Kidney inter 2013 3 (Suppl.)(1) 1 150
   Google Scholar
• Levey AS Becker C Inker LA Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review JAMA 2015 313 8 837 846 25710660
   PubMed Web of Science ®Google Scholar
• Perkins BA Ficociello LH Ostrander BE Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes J Am Soc Nephrol 2007 18 4 1353 1361 17329575
   PubMed Web of Science ®Google Scholar
• Macisaac RJ Jerums G Diabetic kidney disease with and without albuminuria Curr Opin Nephrol Hypertens 2011 20 3 246 257 21422923
   PubMed Web of Science ®Google Scholar
• Molitch ME DeFronzo RA Franz MJ Nephropathy in diabetes Diabetes Care 2004 27 Suppl 1 S79 S83 14693934
   PubMed Web of Science ®Google Scholar
• Heathcote KL Wilson MP Quest DW Wilson TW Prevalence and duration of exercise induced albuminuria in healthy people Clin Invest Med 2009 32 4 261 E265
   PubMed Web of Science ®Google Scholar
• Hogan SL Vupputuri S Guo X Association of cigarette smoking with albuminuria in the United States: the third National Health and Nutrition Examination Survey Ren Fail 2007 29 2 133 142 17365926
   PubMed Web of Science ®Google Scholar
• O-Charoen P Gangcuangco LMA Chow DC Ndhlovu LC Barbour JD Shikuma CM Inflammation and albuminuria in HIV-infected patients receiving combination antiretroviral therapy Hawaii J Med Public Health 2014 73 37
   Google Scholar
• Sharma K The link between obesity and albuminuria: adiponectin and podocyte dysfunction Kidney Int 2009 76 2 145 148 19404275
   PubMed Web of Science ®Google Scholar
• Campion CG Sanchez-Ferras O Batchu SN Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy Can J Kidney Health Dis 2017 4 2054358117705371 28616250
   PubMedGoogle Scholar
• Lee SY Choi ME Urinary biomarkers for early diabetic nephropathy: beyond albuminuria Pediatr Nephrol 2015 30 7 1063 1075 25060761
   PubMed Web of Science ®Google Scholar
• Thomson SE Mclennan SV Twigg SM Growth factors in diabetic complications Expert Rev Clin Immunol 2006 2 3 403 418 20476912
   PubMedGoogle Scholar
• Murad MA Abdulmageed SS Iftikhar R Sagga BK Assessment of the common risk factors associated with type 2 diabetes mellitus in jeddah Int J Endocrinol 2014 2014 1 9
   Web of Science ®Google Scholar
• Kemenkes RI InfoDATIN: Situasi dan Analisis Diabetes 2014 Available from: http://www.pusdatin.kemkes.go.id/folder/view/01/structure-publikasi-pusdatin-info-datin.html Accessed October 3, 2017
   Google Scholar
• Penno G Solini A Bonora E HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes Diab Care 2013 3 1 10
   Google Scholar
• Xu F Zhao LH Su JB The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c Diabetol Metab Syndr 2014 6 1 139 7 25530811
   PubMed Web of Science ®Google Scholar
• Titan SM Vieira JM Dominguez WV Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy J Diabetes Complications 2012 26 6 546 553 22981148
   PubMed Web of Science ®Google Scholar
• Roestenberg P van Nieuwenhoven FA Wieten L Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy Diabetes Care 2004 27 5 1164 1170 15111539
   PubMed Web of Science ®Google Scholar
• Shaker YM Soliman HA Ezzat E Serum and urinary transforming growth factor beta 1 as biochemical markers in diabetic nephropathy patients Beni-Suef Univ J Basic Appl Sci. Elsevier Ltd 2014 3 1 16 23
   Google Scholar
• Rivarola EW Moyses-Neto M Dantas M da-Silva CG Volpini R Coimbra TM Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy Braz J Med Biol Res 1999 32 12 1525 1528 10585634
   PubMed Web of Science ®Google Scholar
• Kim MJ Frankel AH Donaldson M Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin–angiotensin–aldosterone system inhibition Kidney Int 2011 80 8 851 860 21832985
   PubMed Web of Science ®Google Scholar
• Bucala R Vlassara H Advanced glycosylation end products in diabetic renal and vascular disease Am J Kidney Dis 1995 26 6 875 888 7503061
   PubMed Web of Science ®Google Scholar
• Daroux M Prévost G Maillard-Lefebvre H Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies Diabetes Metab 2010 36 1 1 10 19932633
   PubMed Web of Science ®Google Scholar
• Weiss MF Erhard P Kader-Attia FA Mechanisms for the formation of glycoxidation products in end-stage renal disease Kidney Int 2000 57 6 2571 2585 10844627
   PubMed Web of Science ®Google Scholar
• Bohlender JM Franke S Stein G Wolf G Advanced glycation end products and the kidney Am J Physiol Renal Physiol 2005 289 4 F645 F659 16159899
   PubMed Web of Science ®Google Scholar
• Castro NE Kato M Park JT Natarajan R Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells J Biol Chem 2014 289 42 29001 29013 25204661
   PubMed Web of Science ®Google Scholar
• Hellmich B Schellner M Schatz H Pfeiffer A Activation of transforming growth factor-beta1 in diabetic kidney disease Metabolism 2000 49 3 353 359 10726914
   PubMed Web of Science ®Google Scholar
• Hefini S Kamel A El-Banawy H Refai W Khalil G The role of BMP-7 and TGF-ß1 in diabetic nephropathy J Med Res Inst 2007 28 235 243
   Google Scholar
• El Mesallamy HO Ahmed HH Bassyouni AA Ahmed AS Ahmed ME Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy Clin Biochem 2012 45 9 646 650 22421318
   PubMed Web of Science ®Google Scholar
• Yaqiu J Guoliang L Wei K Serum level of transforming growth factor-β and its meaning in diabetic nephropathy J China Med Univ 2001 30 125 132
   Google Scholar
• Bertoluci MC Uebel D Schmidt A Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy Diabetes Res Clin Pract 2006 72 3 258 264 16414143
   PubMed Web of Science ®Google Scholar
• Conserva F Pontrelli P Accetturo M Gesualdo L The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics J Nephrol 2013 26 5 811 820 23543479
   PubMed Web of Science ®Google Scholar
• Houlihan CA Akdeniz A Tsalamandris C Cooper ME Jerums G Gilbert RE Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction Diabetes Care 2002 25 6 1072 1077 12032117
   PubMed Web of Science ®Google Scholar
• Kanwar YS Sun L Xie P Liu FY Chen S A glimpse of various pathogenetic mechanisms of diabetic nephropathy Annu Rev Pathol 2011 6 395 423 21261520
   PubMed Web of Science ®Google Scholar
• Guimarães DA Rizzi E Ceron CS Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension Redox Biol 2015 6 386 395 [Internet]. Elsevier 26343345
   PubMed Web of Science ®Google Scholar
• Jugdutt BI Khan MI Jugdutt SJ Blinston GE Combined captopril and isosorbide dinitrate during healing after myocardial infarction. Effect on ventricular remodeling, function, mass and collagen J Am Coll Cardiol 1995 25 5 1089 96 7897121
   PubMed Web of Science ®Google Scholar
• Richter K Konzack A Pihlajaniemi T Heljasvaara R Kietzmann T Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences Redox Biol 2015 6 344 352 26335400
   PubMed Web of Science ®Google Scholar
• González-Albarrán O Gómez O Ruiz E Vieitez P García-Robles R Role of systolic blood pressureon the progression of kidney damage in an experimental model of type 2 diabetes mellitus, obesity, and hypertension (Zucker rats Am J Hypertens 2003 16 11 Pt 1 979 985 14573338
   PubMed Web of Science ®Google Scholar